Qiagen (QGEN) Tops Q1 EPS by 1c, Approves $100 million Share Repurchase
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
QIAGEN Reports Results for First Quarter of 2019 and Announces Plans for New $100 Million Share Repurchase Program
May 6, 2019 4:05 PM EDTQIAGEN delivers on Q1 2019 outlook Net sales of $348.7 million (+1.5% actual, +6.1% at constant exchange rates, or CER vs. ~5-6% CER outlook) Diluted EPS of $0.13; adj. EPS of $0.27 ($0.28 CER vs. ~$0.26-0.27 CER outlook) Sample to Insight portfolio fueled by dynamic innovation and disruptive solutions FDA approval of new therascreen companion diagnostic for FGFR biomarker QuantiFERON-TB grows 15% CER, benefits of new automation options European rollout progressing for QIAstat-Dx and NeuMoDx automation systems Strong QIAsymphony placements... More
